1 | 94084 | Effects of tamoxifen on the binding and metabolism of testosterone by human prostatic tissue and plasma in vitro. | J Endocrinol | 1979 Dec |
2 |
2 | 121266 | [In vivo occupation of estrogen receptors by hydroxylated metabolites of tamoxifen]. | C R Seances Acad Sci D | 1979 Dec 10 |
1 |
3 | 191185 | Therapeutic use of tamoxifen in advanced breast cancer: correlation with biochemical parameters. | Cancer Treat Rep | 1976 Oct |
2 |
4 | 201053 | Progesterone interaction with estrogen and antiestrogen in the rat uterus--receptor effects. | Steroids | 1977 Aug |
1 |
5 | 207880 | Nonsteroidal antiestrogens: their biological effects and potential mechanisms of action. | J Toxicol Environ Health | 1978 Mar-May |
1 |
6 | 339802 | Hormonal therapy of breast cancer: new approaches and concepts. | Ann Intern Med | 1978 Jan |
1 |
7 | 486127 | Hormonal control of uteroglobin secretion in rabbit uterus: inhibition of uteroglobin synthesis and messenger ribonucleic acid accumulation by oestrogen and anti-oestrogen administration. | Biochem J | 1979 Jun 15 |
5 |
8 | 561688 | Estrogen receptor translocation and replenishment by the antiestrogen tamoxifen. | Endocrinology | 1977 Oct |
1 |
9 | 564384 | Increases in steroid binding globulins induced by tamoxifen in patients with carcinoma of the breast. | J Endocrinol | 1978 Feb |
6 |
10 | 638966 | The use of antiestrogens tamoxifen and nafoxidine in the treatment of human breast cancer in correlation with estrogen receptor values. A phase II study. | Cancer | 1978 Mar |
1 |
11 | 748014 | Estrogen control of progesterone receptor in human breast cancer: role of estradiol and antiestrogen. | Endocrinology | 1978 Nov |
4 |
12 | 798626 | Phase II study of tamoxifen: report of 74 patients with stage IV breast cancer. | Cancer Treat Rep | 1976 Oct |
1 |
13 | 815505 | Tamoxifen as an anti-tumour agent: role of oestradiol and prolactin. | J Endocrinol | 1976 Feb |
1 |
14 | 828517 | Antiestrogenic and antitumor properties of tamoxifen in laboratory animals. | Cancer Treat Rep | 1976 Oct |
3 |
15 | 908269 | Anti-estrogenic compounds increase prolactin and growth hormone synthesis in clonal strains of rat pituitary cells. | Endocrinology | 1977 Oct |
2 |
16 | 918118 | Clinical experiences with tamoxifen for estrogen receptor blocking therapy in metastatic breast cancer. | Prog Clin Biol Res | 1977 |
1 |
17 | 964206 | Induction of uterine ornithine decarboxylase (ODC) by antiestrogens. Inhibition of estradiol-mediated induction of ODC: a possible mechanism of action of antiestrogens. | Endocr Res Commun | 1976 |
4 |
18 | 1024568 | [Effects of the treatment with an antiestrogen(tamoxifen) and levodopa on the secretion of prolactin in patients affected by breast cancer]. | Boll Soc Ital Biol Sper | 1976 Oct 15 |
1 |
19 | 1314079 | Opposite regulation of cAMP concentration in the quail oviduct and the mouse uterus by tamoxifen. Correlation with estrogen-antagonist and estrogen-agonist activity. | J Steroid Biochem Mol Biol | 1992 Mar |
4 |
20 | 1315250 | Evidence that estrogens modulate activity and increase the number of 1,25-dihydroxyvitamin D receptors in osteoblast-like cells (ROS 17/2.8). | Endocrinology | 1992 May |
2 |
21 | 1321770 | Evidence for a role for protein kinase C in the modulation of bombesin-activated cellular signalling in human breast cancer cells. | Mol Cell Endocrinol | 1992 Jun |
1 |
22 | 1322240 | Induction of transforming growth factor beta 1 in human breast cancer in vivo following tamoxifen treatment. | Cancer Res | 1992 Aug 1 |
4 |
23 | 1322985 | A molecular modeling study of the interactions between the antiestrogen drug tamoxifen and several derivatives, and the calcium-binding protein calmodulin. | J Med Chem | 1992 Jul 24 |
2 |
24 | 1350452 | Tamoxifen up-regulates c-erbB-2 expression in oestrogen-responsive breast cancer cells in vitro. | Eur J Cancer | 1992 |
3 |
25 | 1350760 | Tamoxifen attenuates pulsatile growth hormone secretion: mediation in part by somatostatin. | Endocrinology | 1992 Jun |
1 |
26 | 1355980 | Direct effects of tamoxifen on growth hormone secretion by pituitary cells in vitro. | Eur J Cancer | 1992 |
5 |
27 | 1356014 | Hormonal regulation of c-erbB-2 oncogene expression in breast cancer cells. | J Steroid Biochem Mol Biol | 1992 Sep |
1 |
28 | 1359155 | High-dose oral tamoxifen, a potential multidrug-resistance-reversal agent: phase I trial in combination with vinblastine. | J Natl Cancer Inst | 1992 Dec 2 |
2 |
29 | 1360843 | Immunohistochemical determination of P-glycoprotein in a rat mammary tumour treated with tamoxifen. | In Vivo | 1992 Sep-Oct |
3 |
30 | 1373360 | Prospective controlled trial with antiestrogen drug tamoxifen in patients with unresectable hepatocellular carcinoma. | Dig Dis Sci | 1992 May |
1 |
31 | 1380889 | Influence of tamoxifen on plasma levels of insulin-like growth factor I and insulin-like growth factor binding protein I in breast cancer patients. | Cancer Res | 1992 Sep 1 |
7 |
32 | 1381703 | The effect of endocrine therapy with medroxyprogesterone acetate, 4-hydroxyandrostenedione or tamoxifen on plasma concentrations of insulin-like growth factor (IGF)-I, IGF-II and IGFBP-1 in women with advanced breast cancer. | Int J Cancer | 1992 Sep 9 |
6 |
33 | 1394142 | Effects of tamoxifen adjuvant therapy and a low-fat diet on serum binding proteins and estradiol bioavailability in postmenopausal breast cancer patients. | Cancer Res | 1992 Oct 1 |
6 |
34 | 1403692 | Halogenated analogues of tamoxifen: synthesis, receptor assay, and inhibition of MCF7 cells. | J Pharm Sci | 1992 Jul |
2 |
35 | 1403784 | Tamoxifen-resistant human breast cancer cell growth: inhibition by thioridazine, pimozide and the calmodulin antagonist, W-13. | J Pharmacol Exp Ther | 1992 Oct |
1 |
36 | 1417009 | [Aminoglutethimide and aminoglutethimide+tamoxifen treatment for advanced breast cancer]. | Gan To Kagaku Ryoho | 1992 Oct |
1 |
37 | 1418821 | A note on the conformational flexibility of the antiestrogenic drug tamoxifen: preferred conformations in the free state and bound to the protein calmodulin. | Acta Crystallogr B | 1992 Aug 1 |
2 |
38 | 1419616 | Haemostatic changes and thromboembolic risk during tamoxifen therapy in normal women. | Br J Cancer | 1992 Oct |
1 |
39 | 1421427 | Tamoxifen reduces serum insulin-like growth factor I (IGF-I). | Breast Cancer Res Treat | 1992 |
6 |
40 | 1423240 | Modulation of the anti-proliferative signal of interferon-alpha by tamoxifen in U937 cells. | Cancer Lett | 1992 Oct 30 |
1 |
41 | 1426318 | Ovarian steroids modulate human monocyte tumor necrosis factor alpha messenger ribonucleic acid levels in cultured human peripheral monocytes. | Fertil Steril | 1992 Oct |
1 |
42 | 1434657 | Antitumor effect of triphenylethylene derivative (TAT-59) against human breast carcinoma xenografts in nude mice. | J Surg Oncol | 1992 Dec |
1 |
43 | 1465279 | Variations in estrogen and progesterone receptor levels after short-term tamoxifen treatment in breast carcinoma. | Oncology | 1992 |
1 |
44 | 1483948 | Recombinant human interferon-alpha 2a increases hormone receptor level of a human breast carcinoma xenograft in nude mice and enhances the anti-proliferative activity of tamoxifen. | Jpn J Cancer Res | 1992 Dec |
3 |
45 | 1504439 | A new variant of alpha-1-antitrypsin deficiency (Siiyama) associated with pulmonary emphysema. | Intern Med | 1992 May |
1 |
46 | 1516065 | Ectopic expression of epidermal growth factor receptors induces hormone independence in ZR-75-1 human breast cancer cells. | Cancer Res | 1992 Sep 15 |
1 |
47 | 1517237 | Identification of an estrogen response element in the 3'-flanking region of the murine c-fos protooncogene. | J Biol Chem | 1992 Sep 5 |
1 |
48 | 1525393 | Recombinant interferon-alpha 2b affects proliferation, steroid receptors and sensitivity to tamoxifen of cultured breast cancer cells (CG-5). | Anticancer Drugs | 1992 Apr |
2 |
49 | 1525595 | Tamoxifen in the rat prevents estrogen-deficiency bone loss elicited with the LHRH agonist buserelin. | Bone Miner | 1992 Aug |
1 |
50 | 1529443 | The potentiation of 2,3,7,8-tetrachlorodibenzo-p-dioxin toxicity by tamoxifen in female CD1 mice. | Toxicol Appl Pharmacol | 1992 Sep |
2 |